Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension

Marcel Ruzicka; Frans H H Leenen; Tim Ramsay; Ann Bugeja; Cedric Edwards; Brendan McCormick; Swapnil Hiremath

doi:10.1001/jamainternmed.2019.1455

Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension

JAMA Intern Med. 2019 Oct 1;179(10):1433-1434. doi: 10.1001/jamainternmed.2019.1455.

Authors

Marcel Ruzicka^{1

2

3}, Frans H H Leenen⁴, Tim Ramsay², Ann Bugeja^{1

3}, Cedric Edwards^{1

3}, Brendan McCormick^{1

3}, Swapnil Hiremath^{1

2

3}

Affiliations

¹ Renal Hypertension Center, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
² Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
³ Kidney Research Center, University of Ottawa, Ottawa, Ontario, Canada.
⁴ Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Abstract

This cohort study evaluates the association of directly observed therapy with treatment adherencee in patients with apparent treatment-resistant hypertension.